THEODORE F JR CRAVER
CIK 1187019 · Chairman, President and CEO · last filed 2026-05-20
THEODORE F JR CRAVER is a Chairman, President and CEO who has filed 83 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for DUK, was dated May 20, 2026. Across all open-market trades the lifetime net is −$17.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $29.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$29.53M
5
83
-$17.21M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DUK | Director | 31,855 | $129.24 | $4.12M | $289.3K | 16 | 2026-05-20 |
| WFC | Director | 27,201 | $86.87 | $2.36M | $0 | 13 | 2026-05-14 |
| DUKH | Director | 5,738 | $23.73 | $136.1K | $293.0K | 5 | 2018-05-16 |
| HEALTH NET INC (HNT) Delisted | Director | 0 | — | — | -$394.8K | 12 | 2016-03-28 |
| EIX | Chairman, President and CEO | 287,168 | $79.79 | $22.91M | -$17.40M | 37 | 2016-03-10 |
Recent Filings
83 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-20 | DUK | Gift (G) | −2,402 | $0 | EDGAR |
| 2026-05-14 | WFC | Gift (G) | — | $0 | EDGAR |
| 2026-05-11 | DUK | Grant (A) | +2,402 | $299.9K | EDGAR |
| 2026-04-30 | WFC | Grant (A) | — | $0 | EDGAR |
| 2025-08-12 | DUK | Gift (G) | −2,431 | $0 | EDGAR |
| 2025-05-05 | DUK | Grant (A) | +2,431 | $295.0K | EDGAR |
| 2025-05-01 | WFC | Grant (A) | — | $0 | EDGAR |
| 2024-05-21 | DUK | Gift (G) | −1,699 | $0 | EDGAR |
| 2024-05-13 | DUK | Grant (A) | +1,698 | $175.0K | EDGAR |
| 2024-05-02 | WFC | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.